BFRG — Bullfrog AI Holdings, Inc.
Is BFRG overbought or oversold? Here is the current MarketMoodz read.
Bullfrog AI Holdings, Inc. (BFRG) currently reads Strong Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Healthcare name (Health Information Services) last closed at $0.49. The rating moved from Neutral to Strong Oversold on November 17, 2026.
- Public ratingStrong Oversold (as of November 17, 2026)
- Last close$0.49
- Last changeMoved from Neutral to Strong Oversold on November 17, 2026
- SectorHealthcare
- IndustryHealth Information Services
See all oversold Healthcare stocks →
AI analysis
Bullfrog AI Holdings, Inc. (BFRG) is a small, low‑priced equity with limited publicly available financial information. The combination of potential exposure to AI/healthcare technology themes and a constructive risk‑on tape for growth names provides a speculative upside path if the company can demonstrate durable revenue, partnerships, or meaningful product adoption. However, the stock exhibits high execution and dilution risk, low liquidity, and insufficient disclosure for robust fundamental modeling. Near term, price action will likely be driven by discrete news or financing events rather than steady operational improvement.
Key factors
- Micro‑cap equity with limited public disclosures; financial filings and up‑to‑date EDGAR data not available for detailed fundamental validation
- Low share price and likely illiquidity increase volatility and trading spreads
- Exposure to AI and healthcare tech themes could provide long‑term upside if product adoption and partnerships materialize
- Market environment modestly risk‑on with flows into growth, which can help small-cap growth names but increases sensitivity to earnings/news
- No clear recent material corporate developments or visible revenue/profitability track record disclosed in the provided data
Risks
- High dilution risk from potential equity or convertible financings common for early‑stage microcaps
- Limited transparency and lack of recent EDGAR/reporting data impairs ability to model cash runway and revenue traction
- Severe liquidity risk—wide bid/ask spreads and low daily volumes can lead to price gaps on low‑volume news
- Execution risk: product commercialization, customer adoption, or partnership failures could sharply reduce valuation
- Competitive pressure from larger AI/healthcare players and established vendors with greater resources
- Regulatory/contract risk if operating in highly regulated healthcare data or clinical software spaces
Latest MarketMoodz coverage
See today's live rating, score and targets
Members see the live hourly rating for BFRG — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.